178 related articles for article (PubMed ID: 11286688)
1. Mechanism of anti-D-mediated immune suppression--a paradox awaiting resolution?
Kumpel BM; Elson CJ
Trends Immunol; 2001 Jan; 22(1):26-31. PubMed ID: 11286688
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of anti-D action in the prevention of hemolytic disease of the fetus and newborn.
Brinc D; Lazarus AH
Hematology Am Soc Hematol Educ Program; 2009; ():185-91. PubMed ID: 20008198
[TBL] [Abstract][Full Text] [Related]
3. In vivo studies of monoclonal anti-D and the mechanism of immune suppression.
Kumpel BM
Transfus Clin Biol; 2002 Jan; 9(1):9-14. PubMed ID: 11889904
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal anti-D development programme.
Kumpel BM
Transpl Immunol; 2002 Aug; 10(2-3):199-204. PubMed ID: 12216950
[TBL] [Abstract][Full Text] [Related]
5. Increases in anti-Rh(D) titre following pregnancy.
Mollison PL
Vox Sang; 1994; 67(3):326. PubMed ID: 7863638
[No Abstract] [Full Text] [Related]
6. The role of Rh antibodies in haemolytic disease of the newborn.
Hadley AG; Kumpel BM
Baillieres Clin Haematol; 1993 Jun; 6(2):423-44. PubMed ID: 8043933
[TBL] [Abstract][Full Text] [Related]
7. On the immunologic basis of Rh immune globulin (anti-D) prophylaxis.
Kumpel BM
Transfusion; 2006 Sep; 46(9):1652-6. PubMed ID: 16965599
[No Abstract] [Full Text] [Related]
8. Early plasmapheresis followed by high-dose γ-globulin treatment saved a severely Rho-incompatible pregnancy.
Isojima S; Hisano M; Suzuki T; Sago H; Murashima A; Yamaguchi K
J Clin Apher; 2011; 26(4):216-8. PubMed ID: 21506141
[TBL] [Abstract][Full Text] [Related]
9. Fetal RhD genotyping: a more efficient use of anti-D immunoglobulin.
Daniels G; Finning K; Martin P; Summers J
Transfus Clin Biol; 2007 Dec; 14(6):568-71. PubMed ID: 18436463
[TBL] [Abstract][Full Text] [Related]
10. The clinical significance of anti-G in alloimmunized pregnant women.
Hadley A; Poole J; Poole G
Transfusion; 1997 Sep; 37(9):985. PubMed ID: 9308650
[No Abstract] [Full Text] [Related]
11. [Is it advisable to produce anti-Rh0(D) immunoglobulin for the prevention of hemolytic disease of the newborn? (apropos the article by A. A. Mikhaĭlova and N. Ia. Klimova)].
Olovnikova NI; Chertkov IL
Gematol Transfuziol; 1993 Mar; 38(3):38-40. PubMed ID: 8020736
[No Abstract] [Full Text] [Related]
12. Lessons learnt from many years of experience using anti-D in humans for prevention of RhD immunization and haemolytic disease of the fetus and newborn.
Kumpel BM
Clin Exp Immunol; 2008 Oct; 154(1):1-5. PubMed ID: 18727626
[TBL] [Abstract][Full Text] [Related]
13. Immunosuppressive protocols for transplantation and certain hematologic malignancies can prevent the primary immune response to the D blood group antigen.
Seager A; Sandler SG
Immunohematology; 2013; 29(3):110-4. PubMed ID: 24325172
[TBL] [Abstract][Full Text] [Related]
14. [Expanded rhesus prophylaxis].
Maroni ES
Schweiz Rundsch Med Prax; 1987 Nov; 76(45):1254-9. PubMed ID: 2827286
[No Abstract] [Full Text] [Related]
15. Monoclonal anti-D for prophylaxis of RhD haemolytic disease of the newborn.
Kumpel BM
Transfus Clin Biol; 1997 Jul; 4(4):351-6. PubMed ID: 9269715
[TBL] [Abstract][Full Text] [Related]
16. [Epidemiology of anti-D allo-immunization during pregnancy].
Branger B; Winer N
J Gynecol Obstet Biol Reprod (Paris); 2006 Feb; 35(1 Suppl):1S87-1S92. PubMed ID: 16495833
[TBL] [Abstract][Full Text] [Related]
17. Monitoring and treatment of anti-D in pregnancy.
Bettelheim D; Panzer S; Reesink HW; Csapo B; Pessoa C; Guerra F; Wendel S; Calda P; Sprogøe U; Dziegiel M; Aitokallio-Tallberg A; Koskinen S; Kuosmanen M; Legler TJ; Stein W; Villa S; Villa MA; Trespidi L; Acaia B; Vandenbussche FP; Brand A; de Haas M; Kanhai HH; Gounder D; Flanagan P; Donegan R; Parry E; Sefonte C; Skulstad SM; Hervig T; Flesland Ø; Zupańska B; Uhrynowska M; Lapaire O; Zhong XY; Holzgreve W
Vox Sang; 2010 Aug; 99(2):177-92. PubMed ID: 20331536
[TBL] [Abstract][Full Text] [Related]
18. [Promotion of immunization against Rh D antigen following early administration of IgG anti-D during pregnancy?].
Huchet J; Brossard Y
Rev Fr Transfus Immunohematol; 1988 Feb; 31(1):65-9. PubMed ID: 2840729
[No Abstract] [Full Text] [Related]
19. [Social Welfare Board's recommendations for preventive treatment in the origin of Rh immunization].
Högman C; Nilsson BA
Jordemodern; 1987 Oct; 100(10):321-4. PubMed ID: 2826372
[No Abstract] [Full Text] [Related]
20. [Prevention of fetomaternal rhesus-D allo-immunization. Practical aspects].
Cortey A; Brossard Y
J Gynecol Obstet Biol Reprod (Paris); 2006 Feb; 35(1 Suppl):1S123-1S130. PubMed ID: 16495838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
